Gene symbol: Atp5mg

Also known as: Atp5l

Organism: Rattus norvegicus

Summary: Predicted to contribute to proton-transporting ATP synthase activity, rotational mechanism. Involved in ATP metabolic process. Part of mitochondrial proton-transporting ATP synthase complex, coupling factor F(o). Orthologous to several human genes including ATP5MG (ATP synthase membrane subunit g). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 300677 Ensembl:ENSRNOG00000028884 AllianceGenome:RGD:1303259


GO Annotation


Category Term ID Term description
Process GO:0006091 Generation of precursor metabolites and energy
Process GO:0006119 Oxidative phosphorylation
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006163 Purine nucleotide metabolic process
Process GO:0006164 Purine nucleotide biosynthetic process
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006753 Nucleoside phosphate metabolic process
Process GO:0006754 ATP biosynthetic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0008152 Metabolic process
Process GO:0009058 Biosynthetic process
Process GO:0009060 Aerobic respiration
Process GO:0009117 Nucleotide metabolic process
Process GO:0009141 Nucleoside triphosphate metabolic process
Process GO:0009142 Nucleoside triphosphate biosynthetic process
Process GO:0009144 Purine nucleoside triphosphate metabolic process
Process GO:0009145 Purine nucleoside triphosphate biosynthetic process
Process GO:0009150 Purine ribonucleotide metabolic process
Process GO:0009152 Purine ribonucleotide biosynthetic process
Process GO:0009165 Nucleotide biosynthetic process
Process GO:0009199 Ribonucleoside triphosphate metabolic process
Process GO:0009201 Ribonucleoside triphosphate biosynthetic process
Process GO:0009205 Purine ribonucleoside triphosphate metabolic process
Process GO:0009206 Purine ribonucleoside triphosphate biosynthetic process
Process GO:0009259 Ribonucleotide metabolic process
Process GO:0009260 Ribonucleotide biosynthetic process
Process GO:0009987 Cellular process
Process GO:0015980 Energy derivation by oxidation of organic compounds
Process GO:0015986 Proton motive force-driven ATP synthesis
Process GO:0018130 Heterocycle biosynthetic process
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0019637 Organophosphate metabolic process
Process GO:0019693 Ribose phosphate metabolic process
Process GO:0034220 Ion transmembrane transport
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034654 Nucleobase-containing compound biosynthetic process
Process GO:0042776 Proton motive force-driven mitochondrial ATP synthesis
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044281 Small molecule metabolic process
Process GO:0045333 Cellular respiration
Process GO:0046034 ATP metabolic process
Process GO:0046390 Ribose phosphate biosynthetic process
Process GO:0046483 Heterocycle metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0055085 Transmembrane transport
Process GO:0055086 Nucleobase-containing small molecule metabolic process
Process GO:0071704 Organic substance metabolic process
Process GO:0072521 Purine-containing compound metabolic process
Process GO:0072522 Purine-containing compound biosynthetic process
Process GO:0090407 Organophosphate biosynthetic process
Process GO:0098655 Cation transmembrane transport
Process GO:0098660 Inorganic ion transmembrane transport
Process GO:0098662 Inorganic cation transmembrane transport
Process GO:1901135 Carbohydrate derivative metabolic process
Process GO:1901137 Carbohydrate derivative biosynthetic process
Process GO:1901293 Nucleoside phosphate biosynthetic process
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901566 Organonitrogen compound biosynthetic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1902600 Proton transmembrane transport
Component GO:0000276 Mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005739 Mitochondrion
Component GO:0005740 Mitochondrial envelope
Component GO:0005743 Mitochondrial inner membrane
Component GO:0005753 Mitochondrial proton-transporting ATP synthase complex
Component GO:0016020 Membrane
Component GO:0016469 Proton-transporting two-sector ATPase complex
Component GO:0019866 Organelle inner membrane
Component GO:0031090 Organelle membrane
Component GO:0031966 Mitochondrial membrane
Component GO:0031967 Organelle envelope
Component GO:0031975 Envelope
Component GO:0032991 Protein-containing complex
Component GO:0033177 Proton-transporting two-sector ATPase complex, proton-transporting domain
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0045259 Proton-transporting ATP synthase complex
Component GO:0045263 Proton-transporting ATP synthase complex, coupling factor F(o)
Component GO:0098796 Membrane protein complex
Component GO:0098798 Mitochondrial protein-containing complex
Component GO:0098800 Inner mitochondrial membrane protein complex
Component GO:0110165 Cellular anatomical entity
Function GO:0005215 Transporter activity
Function GO:0008324 Cation transmembrane transporter activity
Function GO:0015075 Ion transmembrane transporter activity
Function GO:0015078 Proton transmembrane transporter activity
Function GO:0015318 Inorganic molecular entity transmembrane transporter activity
Function GO:0022857 Transmembrane transporter activity
Function GO:0022890 Inorganic cation transmembrane transporter activity

Expression profile of Atp5mg in omics data



ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 491.66
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 462.195
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 426.35
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 510.464
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 586.364

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.86979
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.78623
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.84004
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 12.00152
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 11.78019
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.12773
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.00829
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.07309
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.07823
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 12.15911
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.11634
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.19101
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.11272
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.08541
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 12.09027
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.24782
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.37585
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.1405
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.16401
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 12.02865
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.22113
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.42028
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.18564
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.28957
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 12.20542
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.07373
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.78451
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.89594
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 11.78348
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 12.19439
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.77536
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.85789
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.7548
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.9277
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 11.85486
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.89342
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 12.07373
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.87925
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 11.84591
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 12.01438
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.01215
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.14361
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.3059
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.35632
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 12.32938

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 213.569946
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 242.458755
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 215.303635
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 177.087311